Market Overview

Alpha Genesis Expands in to European Research Market

Share:

Alpha Genesis, Inc., a leading provider of nonhuman primate research
products and services, has embarked on a further expansion program to
more fully leverage its primate expertise, research design and
integration skills to deliver first-to-market innovations with European
clients.

"Alpha Genesis is a next-generation solution built for today's rapidly
changing primate research environment. Using our deep understanding of
nonhuman primate solutions and our product development expertise, Alpha
Genesis is positioned to take a leading role in the development of new
product extensions throughout Europe," according to a statement from
Senior Alpha Genesis Management. "We are proud of our successful
partnership with leading European academic institutions and the European
pharmaceutical industry and look forward to further assisting these
organizations to adapt to research trends and eliminate potential
disruption in product development."

Alpha Genesis is an AAALAC-accredited primate research institution
headquartered along the I-95 technology corridor. The Company features
comprehensive infrastructure that enables immediate availability of a
broad range of primate models, quick-study start, and innovative
research and animal management processes, with flexible and adaptable
administrative procedures to expeditiously manage client study protocol
development and approval. By providing open investigator access, novel
research applications are seamlessly and rapidly integrated in to
pre-clinical studies to deliver unique and innovative research
management capabilities.

For more information about Alpha Genesis, please visit www.alphagenesisinc.com,
or email us directly at info@alphagenesisinc.com.

View Comments and Join the Discussion!